Reduction of MUC6 Expression Enhances Esophageal Epithelial Barrier Function and Suppresses Epithelial-Mesenchymal Transition in Reflux Esophagitis - Takeaways - MDSpire

Reduction of MUC6 Expression Enhances Esophageal Epithelial Barrier Function and Suppresses Epithelial-Mesenchymal Transition in Reflux Esophagitis

  • By

  • Xue Jia

  • Ying Zhao

  • Hongrui Li

  • Shuaishuai Fan

  • Haiqing Hu

  • January 22, 2026

  • 0 min

Share

  • 1

    Reflux esophagitis (RE) is a chronic inflammatory condition that can lead to serious complications like esophageal ulcers and cancer if untreated.

  • 2

    MUC6 expression is significantly elevated in esophageal tissues of RE patients compared to non-RE patients, indicating its potential role in disease pathology.

  • 3

    Downregulation of MUC6 improves esophageal epithelial barrier function and reduces inflammatory responses in RE, suggesting a therapeutic target.

  • 4

    Current treatments for GERD include medications and surgical interventions, but the rising incidence of RE highlights the need for novel diagnostic biomarkers.

  • 5

    The study emphasizes the importance of MUC6 in esophageal diseases and its potential as a biomarker for early diagnosis and treatment of RE.

Original Source(s)

Reduction of MUC6 Expression Enhances Esophageal Epithelial Barrier Function and Suppresses Epithelial-Mesenchymal Transition in Reflux Esophagitis

  • by Xue Jia, Ying Zhao, Hongrui Li, Shuaishuai Fan, Haiqing Hu

  • January 22, 2026

Related Content

Chinese Physicians' Knowledge, Perspectives, and Clinical Application of Vonoprazan for Treating Helicobacter Pylori Infection and Gastroesophageal Reflux Disease: A Nationwide Cross-Sectional Analysis

Impact of Carbonated Water on Metrics of High-Resolution Esophageal Manometry: A Retrospective Analysis

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.